- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT06566664
Peripheral Neurostimulation
Peripheral nerve blocks are routinely used and highly successful for intra-operative anesthesia and post-operative pain management. Nerve blocks are guided using either neurostimulation as a means to localize the right nerve or by ultrasound guidance or combining the 2 methods. The purpose of this study is to assess whether electrical stimulation improves nerve block quality, beyond its simple purpose of nerve localization.
Studieoversikt
Status
Forhold
Intervensjon / Behandling
Detaljert beskrivelse
The investigators wish to understand how electrical stimulation can affect local anesthetic disposition when performing a peripheral nerve block.
By studying this subject, the investigators open possibilities for improvement on many levels:
increasing the efficacy of the nerve block allows for a reduced onset time, reduced incidence of incomplete block, and prolonged duration of the local anesthetics. This allows for patients to fully benefit from the analgesic properties of the nerve block, allows for a decrease in delays for the operating room readiness, and a allows for a decrease in the amount of medication needed for a successful nerve block. This will decrease side effects and risks of the nerve blocks. Overall better post-surgical pain control may decrease risks for developing chronic post-operative pain, a major post-operative complication.
The results of this study will open the door to novel approaches to manage acute post-operative pain.
Studietype
Registrering (Antatt)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiesteder
-
-
California
-
Stanford, California, Forente stater, 94305
- Stanford University Hospital
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- Undergoing elective upper limb surgery with a planned brachial plexus nerve block
Exclusion Criteria:
- Under 18 years old
- ASA score above III
- Chronic pain condition with daily milligrams of morphine equivalent > 30
- Poorly controlled psychiatric condition
- Coagulopathy
- Active infection
- Moderate, severe or progressing neuropathy
- COPD/Chronic oxygen user
- Pregnancy
- Incarceration
- Unable to consent
- BMI > 35
- Pacemaker
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Dobbelt
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: Ultrasound-guided brachial plexus block with peripheral nerve stimulation
Patients will receive a brachial plexus catheter with ultrasound guidance as per standard of care, with additional use of the B. Braun HNS 12 nerve stimulator during the loading dose of local anesthesia to maintain a gentle twitch. |
Nerve stimulator that is traditionally used for nerve localization during block placements. |
|
Sham-komparator: Ultrasound-guided brachial plexus block without peripheral nerve stimulation
Patients will receive the brachial plexus catheter in the same way the first arm would, and the B Braun nerve stimulator will be placed in the same way, but the ground electrode will not be connected to the patient. |
Stimulator will be placed and turned on, but the grounding electrode will not be connected to prevent nerve stimulation. |
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Onset of Motor Block
Tidsramme: Within 1 hour after the block placement.
|
Determining time when patient experiences first symptoms of local anesthetic action on the upper trunk distribution (median or musculo cutaneous nerve) |
Within 1 hour after the block placement.
|
|
Onset of Sensory Block
Tidsramme: Within 1 hour after the block placement.
|
Determining time when patient experiences first symptoms of local anesthetic action on the superior trunk distribution over the shoulder. |
Within 1 hour after the block placement.
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Skin Temperature Change
Tidsramme: Immediately before and up to 1 hour after neurostimulation and nerve block is performed.
|
Measuring changes in skin temperature over the course of pre and post stimulation and nerve blocking between the blocked and unblocked arms, measured in degrees Celsius. Using Medline Temperature Sensor. |
Immediately before and up to 1 hour after neurostimulation and nerve block is performed.
|
|
When Patient Experiences First Pain
Tidsramme: up to day 7 post operatively
|
Time after surgery at which the patient experiences first sign of pain at the surgical site, as measured by the time for first local anesthetic bolus based on pump device history. |
up to day 7 post operatively
|
|
Time of First Opioid Taken
Tidsramme: Within the first 7 days after surgery
|
As measured by asking patients if they were taking opioids daily after surgery, up to one week. |
Within the first 7 days after surgery
|
|
Total Post Operative MME/Opioid Usage at Day 1
Tidsramme: On Post Operative Day 1
|
Milligram of morphine equivalent, measured by asking patients for amount of pills taken in the last 24 hours (and chart knowledge of prescription mg). |
On Post Operative Day 1
|
|
Total Post Operative MME/Opioid Usage at Day 2
Tidsramme: On Post Operative Day 2
|
Milligram of morphine equivalent, measured by asking patients for amount of pills taken in the last 24 hours (and chart knowledge of prescription mg). |
On Post Operative Day 2
|
|
Total Post Operative MME Opioid Usage at Day 3
Tidsramme: On Post Operative Day 3
|
Milligram of morphine equivalent, measured by asking patients for amount of pills taken in the last 24 hours (and chart knowledge of prescription mg). |
On Post Operative Day 3
|
|
Total Post Operative MME Opioid Usage at Day 4
Tidsramme: On Post Operative Day 4
|
Milligram of morphine equivalent, measured by asking patients for amount of pills taken in the last 24 hours (and chart knowledge of prescription mg). |
On Post Operative Day 4
|
|
Total Post Operative MME Opioid Usage at Day 5
Tidsramme: On Post Operative Day 5
|
Milligram of morphine equivalent, measured by asking patients for amount of pills taken in the last 24 hours (and chart knowledge of prescription mg). |
On Post Operative Day 5
|
|
Total Post Operative MME Opioid Usage at Day 6
Tidsramme: On Post Operative Day 6
|
Milligram of morphine equivalent, measured by asking patients for amount of pills taken in the last 24 hours (and chart knowledge of prescription mg). |
On Post Operative Day 6
|
|
Opioid Usage Assessment at Day 7
Tidsramme: On Post Operative Day 7
|
Milligram of morphine equivalent, measured by asking patients for amount of pills taken in the last 24 hours (and chart knowledge of prescription mg). |
On Post Operative Day 7
|
|
Opioid Usage Assessment at Day 28
Tidsramme: On Post Operative Day 28
|
Milligram of morphine equivalent, measured by asking patients 1) if patients took opioids within the last 3 weeks and 2) if so, how many pills per day. |
On Post Operative Day 28
|
|
Opioid Usage Assessment at 6 Months
Tidsramme: On Post Operative Month 6
|
Milligram of morphine equivalent, measured by asking patients 1) if patients took opioids within the last 5 months and 2) if so, how many pills per day. |
On Post Operative Month 6
|
|
Opioid Usage Assessment at 1 Year
Tidsramme: On Post Operative 1 Year
|
Milligram of morphine equivalent, measured by asking patients 1) if patients took opioids within the last 6 months and 2) if so, how many pills per day. |
On Post Operative 1 Year
|
|
Quality of Recovery
Tidsramme: At Post Operative days 7 and 28 , 6 months, and 1 year
|
Using the standardized -Quality of Recovery 15- at post operative days 7 and 28, 6 months, and 1 year. Each item count on a 0-10 scale where 0 is worst and 10 is best. PART A How have you been feeling in the last 24 hours? (0 to 10, where 0 = none of the time [poor] and 10 = all of the time [excellent]) Q.1 Able to breathe easily Q.2 Been able to enjoy food Q.3 Feeling rested Q.4 Have had a good sleep Q.5 Able to look after personal toilet and hygiene unaided Q.6 Able to communicate with family or friends Q.7 Getting support from hospital doctors and nurses Q.8 Able to return to work or usual home activities Q.9 Feeling comfortable and in control Q.10 Having a feeling of general well-being PART B Have you had any of the following in the last 24 hours? (10 to 0, where 10 = none of the time [excellent] and 0 = all of the time [poor]) Q.11 Moderate pain Q.12 Severe pain Q.13 Nausea or vomiting Q.14 Feeling worried or anxious Q.15 Feeling sad or depressed |
At Post Operative days 7 and 28 , 6 months, and 1 year
|
|
General satisfaction
Tidsramme: At post operative days 0, 1, 7, 28, 6 months, and 1 year
|
General satisfaction on a scale from 1-5 (extremely unsatisfied, unsatisfied, neutral, satisfy, extremely satisfied). Asking patients if they would receive the block again (Y/N). |
At post operative days 0, 1, 7, 28, 6 months, and 1 year
|
|
Adverse Events
Tidsramme: Asked to patients (Check all that apply) at Post Operative Day 0, 1, 7, 28, 6 Months, and 1 Year. Patients have the opportunity to specify in detail for each sympom they select.
|
Numbness, Weakness, Tingling, Breathing Difficulties, Hoarseness |
Asked to patients (Check all that apply) at Post Operative Day 0, 1, 7, 28, 6 Months, and 1 Year. Patients have the opportunity to specify in detail for each sympom they select.
|
|
Catheter Duration Before Discontinuation
Tidsramme: After surgery, up until catheter discontinuation.
|
Patients' catheter duration before discontinuation, as measured by Avoset pump device data. |
After surgery, up until catheter discontinuation.
|
|
Total Local Anesthetic Use with Catheter
Tidsramme: After surgery, up until catheter discontinuation.
|
Patients' local anesthetic use with catheter, as measured by Avoset pump device data. |
After surgery, up until catheter discontinuation.
|
Samarbeidspartnere og etterforskere
Sponsor
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Antatt)
Studiet fullført (Antatt)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- 76523
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
produkt produsert i og eksportert fra USA
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .